Unravelling the stealth effect

被引:90
作者
Butcher, Neville J. [1 ]
Mortimer, Gysell M. [1 ]
Minchin, Rodney F. [1 ]
机构
[1] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia
关键词
PEGYLATION; CLEARANCE; PROTEINS;
D O I
10.1038/nnano.2016.6
中图分类号
TB3 [工程材料学];
学科分类号
082905 [生物质能源与材料];
摘要
Poly(ethylene glycol) helps nanomaterials evade the immune system by modifying the composition of proteins that are adsorbed on the surface of the materials.
引用
收藏
页码:310 / 311
页数:3
相关论文
共 10 条
[1]
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage [J].
Abu Lila, Amr S. ;
Kiwada, Hiroshi ;
Ishida, Tatsuhiro .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :38-47
[2]
Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]
[3]
PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery [J].
Milla, Paola ;
Dosio, Franco ;
Cattel, Luigi .
CURRENT DRUG METABOLISM, 2012, 13 (01) :105-119
[4]
Cryptic Epitopes of Albumin Determine Mononuclear Phagocyte System Clearance of Nanomaterials [J].
Mortimer, Gysell M. ;
Butcher, Neville J. ;
Musumeci, Anthony W. ;
Deng, Zhou J. ;
Martin, Darren J. ;
Minchin, Rodney F. .
ACS NANO, 2014, 8 (04) :3357-3366
[5]
Protein-polymer conjugation - moving beyond PEGylation [J].
Qi, Yizhi ;
Chilkoti, Ashutosh .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2015, 28 :181-193
[6]
Schöttler S, 2016, NAT NANOTECHNOL, V11, P372, DOI [10.1038/NNANO.2015.330, 10.1038/nnano.2015.330]
[7]
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology [J].
Tenzer, Stefan ;
Docter, Dominic ;
Kuharev, Joerg ;
Musyanovych, Anna ;
Fetz, Verena ;
Hecht, Rouven ;
Schlenk, Florian ;
Fischer, Dagmar ;
Kiouptsi, Klytaimnistra ;
Reinhardt, Christoph ;
Landfester, Katharina ;
Schild, Hansjoerg ;
Maskos, Michael ;
Knauer, Shirley K. ;
Stauber, Roland H. .
NATURE NANOTECHNOLOGY, 2013, 8 (10) :772-U1000
[8]
PEGylation, successful approach to drug delivery [J].
Veronese, FM ;
Pasut, G .
DRUG DISCOVERY TODAY, 2005, 10 (21) :1451-1458
[9]
PEGylated proteins: Evaluation of their safety in the absence of definitive metabolism studies [J].
Webster, Rob ;
Didier, Eric ;
Harris, Philip ;
Siegel, Ned ;
Stadler, Jeanne ;
Tilbury, Lorraine ;
Smith, Dennis .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) :9-16
[10]
Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins [J].
Zhang, Fan ;
Liu, Mu-rong ;
Wan, Hai-tong .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (03) :335-339